Article

Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: What is the optimal cut off?

Schön Klinik Bad Bramstedt, Chiemsee, Bavaria, Germany
Annals of the Rheumatic Diseases (Impact Factor: 10.38). 01/2006; 64(12):1773-9. DOI: 10.1136/ard.2005.035279
Source: PubMed

ABSTRACT Previous studies have shown considerable variation in diagnostic performance of enzyme linked immunosorbent assays (ELISAs) for measuring antineutrophil cytoplasmic antibodies (ANCA) specific for proteinase 3 (PR3) and myeloperoxidase (MPO).
To analyse the performance characteristics of different commercially available direct ANCA ELISA kits.
ELISA kits for detecting PR3-ANCA and MPO-ANCA from 11 manufacturers were evaluated. Serum samples were taken from patients with Wegener's granulomatosis (15), microscopic polyangiitis (15), other vasculitides (10), and controls (40).
were compared with data obtained by indirect immunofluorescence (IFT). The diagnostic performance of the tests was analysed and compared by receiver operating characteristic (ROC) curve analysis.Results: Applying the manufacturers' cut off resulted in great variation in sensitivity of the commercial PR3-ANCA kits for diagnosing Wegener's granulomatosis (ranging from 13.3% to 66.7%), and of the MPO-ANCA kits for diagnosing microscopic polyangiitis (ranging from 26.7% to 66.7%). Specificities were relatively constant (from 96.0% to 100%). IFT was superior to all ELISAs (C-ANCA for Wegener's granulomatosis: sensitivity 73.3%, specificity 98%; P-ANCA for microscopic polyangiitis: sensitivity 86.7%, specificity 98%). The sensitivities of PR3-ANCA and MPO-ANCA ELISA kits were increased by lowering the cut off values. This reduced specificity but increased overall diagnostic performance.
The low sensitivity of some commercial kits reflects the high cut off levels recommended rather than methodological problems with the assays. Comparative analyses using sera from well characterised patients may help identify optimum cut off levels of commercial ANCA ELISA tests, resulting in better comparability of results among assays from different manufacturers.

Download full-text

Full-text

Available from: Elena Csernok, Jun 22, 2015
0 Followers
 · 
75 Views
 · 
2 Downloads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Die häufig noch uncharakteristischen Symptome bei Erstmanifestation einer Vaskulitis wie Myalgien, Fieber und Gewichtsverlust führen nicht selten zu Verzögerungen in der Diagnosestellung. Organspezifischere Symptome wie Hämoptysen, Dyspnoe, Epistaxis, Ödeme oder Organinfarkte treten hinzu, wenn als Folge der Vaskulitis bereits eine Funktionsminderung der betroffenen Organsysteme besteht. Eine gezielte serologische Diagnostik, insbesondere die Bestimmung von anti-neutrophilen zytoplasmatischen Antikörpern (ANCA) oder Kryoglobulinen kann eine frühe Diagnosestellung von Kleingefäßvaskulitiden erleichtern. Moderne bildgebende Verfahren wie die Magentresonanztomographie, Computertomographie, Positronenemissionstomographie und Sonographie sind für die Frühdiagnose von Vaskulitiden bedeutsam, da sie eine Diagnose oft noch subklinischer Manifestationen ermöglichen und die Auswahl eines Ortes zur Gewinnung einer Biopsie erleichtern. Die bioptische Sicherung ist immer noch der Goldstandard in der Diagnostik der Vaskulitiden. Funktionell relevante Spätschäden als Folge einer Vaskulitis können durch eine frühzeitig eingeleitete Therapie in ihrer Schwere deutlich reduziert werden. Voraussetzung hierfür ist die möglichst frühe und präzise Diagnosestellung. The often unspecific symptoms like myalgias, fever and weight loss at the onset of vasculitides are a frequent cause for a delay in diagnosis. Organspecific symptoms like hemoptysis, dyspnoea, epistaxis, edema and organ infarcts a present when organ dysfunction occurs as a result of vasculitis. Targeted serologic testing including antineutrophil cytoplasm antibodies (ANCA) and cryoglobulins allows early diagnosis of certain vasculitides. Modern imaging techniques like magnetic resonance imaging, computed tomography, positron-emission tomography and ultrasound are cornerstones for an early diagnosis as they allow the detection of subclinical disease and are helpful in the identification of a site for biopsy. Bioptic proof of vasculitis is still the gold standard for diagnosis. Functionally relevant damage caused by systemic inflammatory disorders can by reduced or sometimes avoided by early initiation of treatment. This requires a correct diagnosis is made as early as possible.
    Zeitschrift für Rheumatologie 11/2005; 64(8):538-546. DOI:10.1007/s00393-005-0794-5 · 0.46 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome, and primary pauci-immune crescentic glomerulonephritis are associated with circulating antineutrophil cytoplasmic autoantibodies (ANCA) (collectively called ANCA-associated vasculitides, AAV). Two types of ANCA, one with a cytoplasmic fluorescence pattern (C-ANCA) and specificity for proteinase 3 (PR3-ANCA) and the other with a perinuclear pattern (P-ANCA) and specificity for myeloperoxidase (MPO-ANCA), account for this association and are highly specific markers for these vasculitides. AAV most often require therapy with cytotoxic and antiinflammatory agents, and hence a well-established diagnosis is mandatory to avoid unnecessary and risky treatment. The widespread use of ANCA screening in the past decade has resulted in the occurrence of greater numbers of false-positive results and has led to greater difficulty in test interpretation. Methods for ANCA detection have been standardized internationally in large multicentre studies and an international consensus statement on testing and reporting of ANCA has been pub lished (1999 and 2003). Despite these advances, problems with the extended use of ANCA testing in daily clinical practice remain. They may be summarized as follows: (1) the basic standards for ANCA testing are not uniformly met; (2) there is still controversy over the value of formalin fixation of neutrophils in differentiating P-ANCA from antinuclear antibodies (what is the place of this substrate in ANCA testing?); (3) the new generation of PR3-ANCA and MPO-ANCA ELISAs are more sensitive and specific than immunofluorescence testing (should ELISAs replace the immunofluorescence test?); and (4) should alternative methods for ANCA detection such as image analysis and/or multiplex immunoassays be used for screening? In this paper, we review these issues, identify areas of uncertainty, and provide practical guidelines where possible.
    Autoimmunity Highlights 05/2010; 1(1):39-43. DOI:10.1007/s13317-010-0007-3
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The often unspecific symptoms like myalgias, fever and weight loss at the onset of vasculitides are a frequent cause for a delay in diagnosis. Organ-specific symptoms like hemoptysis, dyspnoea, epistaxis, edema and organ infarcts a present when organ dysfunction occurs as a result of vasculitis. Targeted serologic testing including antineutrophil cytoplasm antibodies (ANCA) and cryoglobulins allows early diagnosis of certain vasculitides. Modern imaging techniques like magnetic resonance imaging, computed tomography, positron-emission tomography and ultrasound are cornerstones for an early diagnosis as they allow the detection of subclinical disease and are helpful in the identification of a site for biopsy. Bioptic proof of vasculitis is still the gold standard for diagnosis. Functionally relevant damage caused by systemic inflammatory disorders can by reduced or sometimes avoided by early initiation of treatment. This requires a correct diagnosis is made as early as possible.
    Zeitschrift für Rheumatologie 12/2005; 64(8):538-46. · 0.46 Impact Factor
Show more